Rifampicin 300 mg Capsules

DRUG2 trials

Sponsors

Leiden University Medical Center, Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Conditions

TUBERCULOSISprosthetic joint infection

Phase 2

Safety of Rifampicin at High Dose for the Treatment of Adult Subjects with Complex Drug Susceptible Pulmonary and Extrapulmonary Tuberculosis

Not yet recruitingCTIS2024-519983-42-00

Fundacio Hospital Universitari Vall D’Hebron Institut De RecercaTUBERCULOSIS

Target: 50Updated: 2025-02-04

Phase 4

Rifampicin Combination Therapy versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection

RecruitingCTIS2022-501620-26-00

Leiden University Medical Centerprosthetic joint infection

Start: 2023-05-15Target: 316Updated: 2025-07-07

Related Papers

RIFAMPICIN COMBINATION THERAPY VERSUS TARGETED ANTIMICROBIAL MONOTHERAPY IN THE ORAL ANTIMICROBIAL TREATMENT PHASE OF STAPHYLOCOCCAL PROSTHETIC JOINT INFECTION (RICOTTA-TRIAL): PROTOCOL FOR A RANDOMIZED, CONTROLLED, OPEN-LABEL, NON-INFERIORITY TRIAL

Orthopaedic Proceedings2024-11-221 citations